Samsung, Biogen Idec form $300M biosimilars joint venture

Samsung Biologics, the drug manufacturing business that a South Korean conglomerate formed earlier this year with the help of pharmaceutical services firm Quintiles, is partnering on a $300 million initiative with Biogen Idec (NASDAQ:BIIB). The joint venture, which will be based in South Korea, will develop, manufacture and market biosimilars, biological products that are similar […]


Biogen Idec gets European approval on injectible pen for MS drug

Biogen Idec (NASDAQ:BIIB) has received European approval on an injectable pen that delivers its top-selling multiple sclerosis drug Avonex. Avonex is used as a treatment for relapsing forms of MS. The drug slows the progression of physical disability and reduces relapses. Weston, Massachusetts-based Biogen Idec makes Avonex at a manufacturing facility in North Carolina’s Research […]